Profile for Denmark Patent: 2176231
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Denmark Patent: 2176231
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 8,299,057 | Mar 10, 2032 | Genentech Inc | ROZLYTREK | entrectinib |
| 8,673,893 | Jul 8, 2028 | Genentech Inc | ROZLYTREK | entrectinib |
| 9,029,356 | Jul 8, 2028 | Genentech Inc | ROZLYTREK | entrectinib |
| 9,085,558 | Jul 8, 2028 | Genentech Inc | ROZLYTREK | entrectinib |
| 9,255,087 | Jul 8, 2028 | Genentech Inc | ROZLYTREK | entrectinib |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
